Check-Cap Ltd. (NASDAQ:CHEK – Get Free Report) shares passed below its 50-day moving average during trading on Monday . The stock has a 50-day moving average of $0.94 and traded as low as $0.80. Check-Cap shares last traded at $0.91, with a volume of 40,498 shares changing hands.
Analyst Upgrades and Downgrades
Separately, StockNews.com began coverage on Check-Cap in a research note on Tuesday. They set a “sell” rating for the company.
Read Our Latest Research Report on CHEK
Check-Cap Stock Performance
About Check-Cap
Check-Cap Ltd., a clinical stage medical diagnostics company, engages in the development of a capsule-based screening technology that utilizes ultra-low-dose X-rays to scan the inner lining of the colon for precancerous polyps, and other structural abnormalities in Israel. Its C-Scan system consists of C-Scan Cap, an X-ray scanning capsule for detection of suspected polyps; C-Scan Track, a disposable system attached to the patient's back through biocompatible adhesive skin patches; and C-Scan View software, a client/server-based application that enables procedure data download from the C-Scan Track, data analysis, and report generation.
Recommended Stories
- Five stocks we like better than Check-Cap
- Using the MarketBeat Dividend Tax Calculator
- Super Micro Stock: $7.2M Call Options Signal Big Upside Potential
- Best of the list of Dividend Aristocrats: Build wealth with the aristocrat index
- Top 3 Buy-and-Hold Stocks for 2025: Long-Term Winners to Watch
- ESG Stocks, What Investors Should Know
- D-Wave Stock: Is Quantum Blockchain the Next Big Catalyst?
Receive News & Ratings for Check-Cap Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Check-Cap and related companies with MarketBeat.com's FREE daily email newsletter.